GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+36.83%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$903M
AUM Growth
+$903M
(+25%)
Cap. Flow
+$5.17M
Cap. Flow
% of AUM
0.57%
Top 10 Holdings %
Top 10 Hldgs %
61.67%
Holding
50
New
8
Increased
5
Reduced
11
Closed
11
Top Buys
| 1 |
Ascendis Pharma
ASND
|
$48.8M |
| 2 |
GNFT
Genfit
GNFT
|
$29.5M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$26.9M |
| 4 |
PTC Therapeutics
PTCT
|
$22.2M |
| 5 |
DERM
Dermira, Inc.
DERM
|
$20.3M |
Top Sells
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$24.7M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$20.2M |
| 3 |
Cytokinetics
CYTK
|
$20.1M |
| 4 |
Puma Biotechnology
PBYI
|
$18.6M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$13.6M |
Sector Composition
| 1 | Healthcare | 97.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PTC Therapeutics
PTCT
$3.92B
| $68.3M | 6.76% | 1,814,260 +589,260 | +48% | +$22.2M |
|
|
ZGNX
2
DELISTED
Zogenix, Inc.
ZGNX
| $66M | 6.53% | 1,199,545 +199,545 | +20% | +$11M |
|
|
GBT
3
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $62.5M | 6.18% | 1,180,000 | – | – |
|
|
BOLD
4
DELISTED
Audentes Therapeutics, Inc
BOLD
| $61.4M | 6.07% | 1,572,618 -85,255 | -5% | -$3.33M |
|
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $53.7M | 5.32% | 2,000,000 -752,256 | -27% | -$20.2M |
|
6
Iovance Biotherapeutics
IOVA
$807M
| $52.9M | 5.24% | 5,567,348 | – | – |
|
|
XLRN
7
DELISTED
Acceleron Pharma Inc.
XLRN
| $50.3M | 4.98% | 1,080,113 +43,538 | +4% | +$2.03M |
|
|
8
Ascendis Pharma
ASND
$11.8B
| $48.8M | 4.83% | +415,000 | New | +$48.8M |
|
|
9
BioCryst Pharmaceuticals
BCRX
$1.74B
| $48.5M | 4.8% | 5,955,762 -1,666,494 | -22% | -$13.6M |
|
10
United Therapeutics
UTHR
$13.8B
| $44.6M | 4.41% | 379,832 +29,032 | +8% | +$3.41M |
|
|
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
| $43.9M | 4.34% | 1,800,000 -50,000 | -3% | -$1.22M |
|
12
Kura Oncology
KURA
$686M
| $43.9M | 4.34% | 2,645,100 -124,427 | -4% | -$2.06M |
|
|
13
Puma Biotechnology
PBYI
$254M
| $34.9M | 3.46% | 900,000 -479,700 | -35% | -$18.6M |
|
|
FPRX
14
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $32.1M | 3.18% | 2,398,409 | – | – |
|
|
GNFT
15
Genfit
GNFT
$200M
| $29.5M | 2.92% | +1,230,314 | New | +$29.5M |
|
|
EPZM
16
DELISTED
Epizyme, Inc
EPZM
| $26.9M | 2.67% | +2,173,913 | New | +$26.9M |
|
|
DERM
17
DELISTED
Dermira, Inc.
DERM
| $20.3M | 2.01% | +1,500,000 | New | +$20.3M |
|
18
Tempest Therapeutics
TPST
$44M
| $19.3M | 1.91% | 1,288,093 | – | – |
|
19
Krystal Biotech
KRYS
$4.27B
| $16.2M | 1.6% | 492,100 | – | – |
|
20
VYNE Therapeutics
VYNE
$8.16M
| $16.1M | 1.6% | 2,057,027 -147,380 | -7% | -$1.16M |
|
|
CBAY
21
DELISTED
Cymabay Therapeutics
CBAY
| $13.3M | 1.31% | 998,841 -419,648 | -30% | -$5.57M |
|
22
CytomX Therapeutics
CTMX
$336M
| $10.3M | 1.02% | +959,077 | New | +$10.3M |
|
|
FOMX
23
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $10.1M | 1% | 2,697,133 -1,350,428 | -33% | -$5.06M |
|
24
Larimar Therapeutics
LRMR
$310M
| $8.52M | 0.84% | 3,110,874 -487,518 | -14% | -$1.34M |
|
|
RVLP
25
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $5.4M | 0.53% | 1,500,000 | – | – |
|